1Rossouw JE;Anderson GL;Prentice RL.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal result from the Women's Health Initiative randomized controlled trial,2002. 被引量：1
2Grady D;Herrington D;Bittner V.Cardiovascular disease outcomes during 6.8 years of hormone therapy[J],2002(1). 被引量：1
3Hully S;Furberg C;Barrett Connor E.Noncardiovascular disease outcomes during 6.8 years of hormone therapy:Heart and Estrogen/progestin Replacement Study follow-up(HERSⅡ)[J],2002(1). 被引量：1
3Hodis HN, Mack WJ. Postmenopausal hormone therapy and cardiovascular disease in perspective. Clin Obstet Gynecol. 2008, 51 (3) :564-580. 被引量：1
4Martin KA, Manson JE. Approach to the patient with menopausal symptoms. J Clin Endocrinol Metab, 2008, 93 (12) :4567-4575. 被引量：1
5Christante D, Pommier S, Garreau J, et al. Improved breast cancer survival among hormone therapy users is durable after 5 years of additional follow-up. Am J Surg, 2008,196(4) :505-511. 被引量：1
6All I, James T, Meston N, et al. Age and hormone therapy as factors influencing androgen levels in the postmenopausal female. Clin Chem Lab Med, 2009,47(2) :202-207. 被引量：1
7Hachul H, Bittencourt LR, Andersen ML, et al. Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women. Int J Gynaecol Obstet, 2008,103 (3) : 207- 212. 被引量：1
10The IMS Executive Committee. Guidelines for hormone treatment of women in the menopausal transition and beyond [ J ]. Maturitas, 2005,51 : 15-20. 被引量：1
